DDX5 and hepatocellular carcinoma: Our earlier studies suggested a role for DDX5 in poor prognosis HCC [22], and that DDX5 knockdown enables HCC cells to form hepatospheres, exhibiting growth insensitive to sorafenib [24] by an unknown mechanism.